| Literature DB >> 27772791 |
Wenxian Li1, Youzhen Feng2, Weibiao Lu1, Xie Xie1, Zhilin Xiong1, Zhen Jing1, Xiangran Cai2, Li'an Huang3.
Abstract
PURPOSE: To determine the morphological changes of intracranial arteries and whole-brain perfusion in undetermined isolated vertigo (UIV) patients using 320-detector row computed tomography (CT).Entities:
Keywords: 320-detector row computed tomography; Cerebral perfusion; Morphological changes of intracranial arteries; Undetermined isolated vertigo; Vascular risk factors
Mesh:
Year: 2016 PMID: 27772791 PMCID: PMC5082828 DOI: 10.1016/j.jns.2016.09.024
Source DB: PubMed Journal: J Neurol Sci ISSN: 0022-510X Impact factor: 3.181
Fig. 1Outlines of ROIs (indicated by red circles) consisting of diffusion-weighted MR, CT scans and corresponding perfusion maps including relative cerebral blood volume (rCBV), time to peak (TTP), relative cerebral blood flow (rCBF), and mean transit time (MTT).
(A. Frontal cortex and parietal cortex. B. Frontal lobe. C. Internal capsule, striatum and thalamus. D. Superior side of temporal lobe. E. Occipitotemporal lobe. F. Cerebellum. G. Brainstem.)
Baseline and radiological characteristics among three groups.
| Characteristics | UIV group | BPPV group | Control group | |
|---|---|---|---|---|
| General demographic data | ||||
| Age, y, mean ± SD | 61.59 ± 11.07 | 59.04 ± 11.78 | 58.75 ± 14.36 | > 0.05 |
| Sex, F/M | 37/39 | 46/28 | 32/28 | > 0.05 |
| VRFs [n(%)] | ||||
| Age ≥ 60 years | 40 (52.63) | 37 (50.00) | 26 (43.33) | > 0.05 |
| HT | 60 (78.95) | 32 (43.24) | 22 (36.67) | < 0.0125 |
| DM | 20 (26.32) | 7 (9.46) | 11 (18.33) | 0.027 |
| Dyslipidemia | 40 (52.63) | 23 (31.01) | 16 (26.67) | < 0.0125 |
| CHD | 11 (14.47) | 6 (8.11) | 6 (10.00) | > 0.05 |
| Smoking | 18 (23.68) | 10 (13.51) | 8 (13.33) | > 0.05 |
| Number of VRFs ≥ 3 | 47 (61.84) | 14 (18.92) | 21 (35.00) | < 0.0125 |
| Intracranial vascular morphology changes [n(%)] | ||||
| ACA stenosis/hypoplasia | 2 (2.63)/2 (2.63) | 1 (1.35)/4 (5.41) | 1 (1.67)/0 (0.00) | > 0.05 |
| MCA stenosis | 9 (11.84) | 3 (4.05) | 6 (10.00) | > 0.05 |
| PCA stenosis/hypoplasia | 5 (6.58)/3 (3.95) | 0 (0.00)/1 (1.35) | 2 (3.33)/2 (3.33) | > 0.05 |
| VAS | 8 (10.53) | 0 (0.00) | 0 (0.00) | < 0.0125 |
| VAO | 2 (2.63) | 1 (1.35) | 3 (5.00) | > 0.05 |
| VAD(VAH) | 53 (69.74) | 29 (39.19) | 14 (23.33) | < 0.0125 |
| Direction of VAD(VAH) | ||||
| L side | 33 (43.42) | 19 (25.68) | 12 (20.00) | |
| R side | 20 (26.32) | 10 (13.51) | 2 (3.33) | |
| BAS | 4 (5.26) | 0 (0.00) | 2 (3.33) | > 0.05 |
| BAH | 7 (9.21) | 1 (1.35) | 2 (3.33) | > 0.05 |
| BAC | 49 (64.47) | 32 (43.24) | 19 (31.67) | < 0.0125 |
| Direction of BAC | ||||
| L side | 6 (7.89) | 10 (13.51) | 5 (8.33) | |
| R side | 38 (50.00) | 16 (21.62) | 13 (21.67) | |
| Unclassification side | 5 (6.58) | 6 (8.11) | 1 (1.67) | |
| Type of BAC | ||||
| C-type | 27 (35.53) | 9 (12.16) | 7 (11.67) | |
| J-type | 19 (25.00) | 17 (22.97) | 10 (16.67) | |
| S-type | 3 (3.95) | 6 (8.11) | 2 (3.33) | |
| Degree of BAC | ||||
| Grade 0 | 27 (35.53) | 42 (56.76) | 41 (68.33) | < 0.0125 |
| Grade 1 | 23 (30.26) | 24 (32.43) | 12 (20.00) | > 0.05 |
| Grade 2 | 21 (27.63) | 7 (9.46) | 4 (6.67) | < 0.0125 |
| Grade 3 | 5 (6.58) | 1 (1.35) | 3 (5.00) | > 0.05 |
| Moderate to severe | 26 (34.21) | 8 (10.81) | 7 (11.67) | < 0.0125 |
UIV indicates undetermined isolated vertigo; BPPV, benign paroxysmal positional vertigo; VRFs, vascular risk factors; HT, hypertension; DM, diabetes mellitus; CHD, coronary heart disease; ACA, anterior cerebral artery; MCA, middle cerebral artery; PCA, posterior cerebral artery; VAS, vertebral artery stenosis; VAO, vertebral artery occlusion; VAD, vertebral artery dominance; VAH, vertebral artery hypoplasia; L, left; R, right; BAS, basilar artery stenosis; BAH, basilar artery hypoplasia; BAC, basilar artery curvature.
Statistical significance was observed in UIV vs. (BPPV and/or Control), (P < 0.0125, respectively), and no statistical significance was observed in BPPV vs. Control (P > 0.05, respectively). “P > 0.05” means there were no statistically significant differences among the three groups, or between any two groups.
Presence of a relative stenosis/occlusion on the smaller VAa or BAHb side in UIV patients.
| VAS/VAO | Non-VAS/VAO | BAH side | Normal BA | ||||
|---|---|---|---|---|---|---|---|
| Smaller VA | 9 (90.00) | 3 (4.55) | 0.000 | BAS | 4 (57.14) | 0 (0.00) | 0.000 |
| Normal VA | 1 (10.00) | 63 (95.45) | Non-BAS | 3 (42.86) | 69 (100.00) | ||
| VRFs ≥ 3 | 7 (70.00) | 46 (69.70) | > 0.05 | 4 (57.14) | 42 (60.87) | > 0.05 | |
| VRFs < 3 | 3 (30.00) | 20 (30.30) | 3 (42.86) | 27 (39.13) |
All values given as absolute numbers (%). VAS, vertebral artery stenosis; VAO, vertebral artery occlusion; BAH, basilar artery hypoplasia; BAS, basilar artery stenosis; VRFs, vascular risk factors.
Defined by the smaller VA diameter side including the opposite side to the vertebral artery dominance and vertebral artery hypoplasia side.
Defined by the as a basilar artery diameter < 2 mm.
Fig. 2The absolute difference in relative values of CTP parameters from cerebellum and brainstem ROIs among the three groups.
(A. Absolute relative cerebral blood volume (arCBV). B. Absolute relative cerebral blood flow (arCBF). C. Absolute mean transit time (aMTT). D. Absolute time to peak (aTTP).)
*Significant statistical difference compared with the other two groups.
Presence of a relative cerebellar and brainstem hypoperfusion in the non-VADa and BAC cohort with UIV patients.
| Indicators (n) | Hypoperfusion | No hypoperfusion | |
|---|---|---|---|
| Non-VAD side (n = 53) | 44 (83.02) | 9 (16.98) | 0.002 |
| Normal VA (n = 23) | 11 (47.83) | 12 (52.17) | |
| Non-VAD side (n = 53) | 35 (66.04) | 18 (33.96) | 0.000 |
| VAD side (n = 53) | 10 (18.87) | 43 (81.13) | |
| BAC (n = 49) | 39 (79.59) | 10 (20.41) | 0.012 |
| Normal BA (n = 27) | 14 (51.85) | 13 (48.15) | |
| Opposite of BAC | 34 (77.27) | 10 (22.73) | 0.000 |
| BAC side (n = 44) | 7 (15.91) | 37 (84.09) |
All values given as absolute numbers (%). VAD, vertebral artery dominance; BA, basilar artery; BAC, basilar artery curvature.
Defined by the opposite side to the vertebral artery dominance and vertebral artery hypoplasia, stenosis or occlusion.
Defined by the opposite direction side to BAC, and clear basilar artery “C” or “J” type curvature toward either the left or the right sides.
Presence of a relative cerebellar and brainstem hypoperfusion in the non-VADa and BAC cohort with UIV patients.
| Indicators (n) | Hypoperfusion | No hypoperfusion | |
|---|---|---|---|
| Non-VAD cohort (n = 43) | 35 (81.40) | 8 (18.60) | 0.005 |
| Normal VA cohort (n = 23) | 11 (47.83) | 12 (52.17) | |
| Non-VAD side (n = 43) | 26 (60.47) | 17 (39.53) | 0.000 |
| VAD side (n = 43) | 9 (20.93) | 34 (79.07) | |
| BAC | 30 (76.92) | 9 (23.08) | 0.034 |
| Normal BA cohort (n = 27) | 14 (51.85) | 13 (48.15) | |
| Opposite of BAC | 25 (69.44) | 11 (30.56) | 0.000 |
| BAC side (n = 36) | 5 (13.89) | 31 (86.11) |
All values given as absolute numbers (%). VAD, vertebral artery dominance; BA, basilar artery; BAC, basilar artery curvature.
Defined by the opposite side to the VAD and VAH, and exclude stenosis or occlusion.
Defined by the BAC cohort, exclude VAS or VAO, BAS.
Defined by the opposite direction side to BAC, and clear “C” or “J” type curvature toward either the left or the right sides. And exclude VAS or VAO, BAS.
Fig. 3A UIV patient with left VAH, left BAC and a regional hypoperfusion in the dependent territory of left VAH on CTP image (indicated by red circles). The ipsilateral VAH and BAC are marked by a red arrow. The diffusion-weighted MRI scans show no diffusion restriction indicative of cerebellar infarction.
(A. CTA imaging. B. The corresponding image of diffusion-weighted MR image scan. C. Digital subtraction of 3D reconstructions of CTA imaging. D. The corresponding image of CT scan.)
Fig. 4A patient with left VAH and BAC. A regional hypoperfusion in the dependent territory of right BAC and left VAH on CTP imaging (indicated by red circles). The ipsilateral BAC and VAH are marked by a red arrow.
(A. Left BAC on CTA scan. B. Left VAH on CTA scan.)